{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:56Z","timestamp":1794047396413,"version":"4.8.0"},"reference-count":29,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Vector-based SARS-CoV-2 vaccines have been associated with vaccine- induced thrombosis with thrombocytopenia syndrome (VITT\/TTS), but the causative factors are still unresolved. We comprehensively analyzed the ChAdOx1 nCoV-19 (AstraZeneca) and Ad26.COV2.S (Johnson and Johnson) vaccines. ChAdOx1 nCoV-19 contains significant amounts of host cell protein impurities, including functionally active proteasomes, and adenoviral proteins. A much smaller amount of impurities was found in Ad26.COV2.S. Platelet factor 4 formed complexes with ChAdOx1 nCoV-19 constituents, but not with purified virions from ChAdOx1 nCoV-19 or with Ad26.COV2.S. Vascular hyperpermeability was induced by ChAdOx nCoV-19 but not by Ad26.COV2.S. These differences in impurities together with EDTAinduced capillary leakage might contribute to the higher incidence rate of VITT associated with ChAdOx1 nCoV-19 compared to Ad26.COV2.S.<\/jats:p>","DOI":"10.3324\/haematol.2021.280154","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T03:20:38Z","timestamp":1642648838000},"page":"947-957","source":"Crossref","is-referenced-by-count":53,"title":["Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines"],"prefix":"10.3324","volume":"107","author":[{"given":"Stephan","family":"Michalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Siegerist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Palankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Franzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Cammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Steil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hentschker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gesell-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Endlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"34913","doi-asserted-by":"crossref","unstructured":"Sadoff J, Gray G, Vandebosch A. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021; 384(23):2187-2201.","DOI":"10.1056\/NEJMoa2101544"},{"key":"34914","doi-asserted-by":"crossref","unstructured":"Voysey M, Clemens SAC, Madhi SA. Safety and efficacy of the ChAdOx1 nCoV- 19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021; 397(10269):99-111.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"34915","doi-asserted-by":"crossref","unstructured":"See I, Lale A, Marquez P. Case series of thrombosis with thrombocytopenia syndrome following COVID-19 vaccination\u2014 United States, December 2020\u2013August 2021.Publisher","DOI":"10.1101\/2021.11.10.21266063"},{"key":"34916","doi-asserted-by":"crossref","unstructured":"Chevassut T, Hunt BJ, Pavord S. VITT, COVID-19 and the Expert Haematology Panel: the story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme. Clin Med (Lond). 2021; 21(6):e600-e602.","DOI":"10.7861\/clinmed.2021-0488"},{"key":"34917","unstructured":"Paul-Ehrlich-Institut Germany. Sicherheitsbericht: Verdachtsf\u00e4lle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19 seit Beginn der Impfkampagne am 27.12.2020 bis zum 30.09.2021 [accessed Dec 6, 2021].Publisher"},{"key":"34918","doi-asserted-by":"crossref","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021; 384(22):2092-2101.","DOI":"10.1056\/NEJMoa2104840"},{"key":"34919","doi-asserted-by":"crossref","unstructured":"Scully M, Singh D, Lown R. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021; 384(23):2202-2211.","DOI":"10.1056\/NEJMoa2105385"},{"key":"34920","doi-asserted-by":"crossref","unstructured":"Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I. Antibody epitopes in vaccineinduced immune thrombotic thrombocytopaenia. Nature. 2021; 596(7873):565-569.","DOI":"10.1038\/s41586-021-03744-4"},{"key":"34921","doi-asserted-by":"crossref","unstructured":"Greinacher A, Selleng K, Palankar R. Insights in ChAdOx1 nCoV-19 vaccineinduced immune thrombotic thrombocytopenia. Blood. 2021; 138(22):2256-2268.","DOI":"10.1182\/blood.2021013231"},{"key":"34922","unstructured":"Krutzke L, Roesler R, Wiese S, Kochanek S. Process-related impurities in the ChAdOx1 nCov-19 vaccine [accessed May 4, 2021].Publisher"},{"key":"34923","doi-asserted-by":"crossref","unstructured":"Nickerson JL, Doucette AA. Rapid and quantitative protein precipitation for proteome analysis by mass spectrometry. J Proteome Res. 2020; 19(5):2035-2042.","DOI":"10.1021\/acs.jproteome.9b00867"},{"key":"34924","doi-asserted-by":"crossref","unstructured":"Blankenburg S, Hentschker C, Nagel A. Improving proteome coverage for small sample amounts: an advanced method for proteomics approaches with low bacterial cell numbers. Proteomics. 2019; 19(23):e1900192.","DOI":"10.1002\/pmic.201900192"},{"key":"34925","doi-asserted-by":"crossref","unstructured":"Perez-Riverol Y, Csordas A, Bai J. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019; 47(D1):D442-D450.","DOI":"10.1093\/nar\/gky1106"},{"key":"34926","doi-asserted-by":"crossref","unstructured":"Berkers CR, Verdoes M, Lichtman E. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. Nat Methods. 2005; 2(5):357-362.","DOI":"10.1038\/nmeth759"},{"key":"34927","doi-asserted-by":"crossref","unstructured":"Arastu-Kapur S, Anderl JL, Kraus M. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events. Clin Cancer Res. 2011; 17(9):2734-2743.","DOI":"10.1158\/1078-0432.CCR-10-1950"},{"key":"34928","doi-asserted-by":"crossref","unstructured":"Provost A, Rousset C, Bourdon L. Innovative particle standards and long-lived imaging for 2D and 3D dSTORM. Sci Rep. 2019; 9(1):17967.","DOI":"10.1038\/s41598-019-53528-0"},{"key":"34929","doi-asserted-by":"crossref","unstructured":"Laine RF, Tosheva KL, Gustafsson N. NanoJ: a high-performance open-source super-resolution microscopy toolbox. J Phys D Appl Phys. 2019; 52(16):163001.","DOI":"10.1088\/1361-6463\/ab0261"},{"key":"34930","doi-asserted-by":"crossref","unstructured":"Hoboth P, \u0160ebesta O, Sztacho M, Castano E, Hoz\u00e1k P. Dual-color dSTORM imaging and ThunderSTORM image reconstruction and analysis to study the spatial organization of the nuclear phosphatidylinositol phosphates. MethodsX. 2021; 8:101372.","DOI":"10.1016\/j.mex.2021.101372"},{"key":"34931","doi-asserted-by":"crossref","unstructured":"Schindelin J, Arganda-Carreras I, Frise E. Fiji: an open-source platform for biologicalimage analysis. Nat Methods. 2012; 9(7):676-682.","DOI":"10.1038\/nmeth.2019"},{"key":"34932","doi-asserted-by":"crossref","unstructured":"Xie J, Farage E, Sugimoto M, Anand-Apte B. A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev Biol. 2010; 10:76.","DOI":"10.1186\/1471-213X-10-76"},{"key":"34933","doi-asserted-by":"crossref","unstructured":"Siegerist F, Zhou W, Endlich K, Endlich N. 4D in vivo imaging of glomerular barrier function in a zebrafish podocyte injury model. Acta Physiol (Oxf). 2017; 220(1):167-173.","DOI":"10.1111\/apha.12754"},{"key":"34934","doi-asserted-by":"crossref","unstructured":"Baker AT, Boyd RJ, Sarkar D. ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Sci Adv. 2021; 7(49):eabl8213.","DOI":"10.1126\/sciadv.abl8213"},{"key":"34935","unstructured":"Eurpean Medicines Agency (EMA). Assessment report: COVID-19 Vaccine AstraZeneca [accessed Dec 6, 2021].Publisher"},{"key":"34936","unstructured":"Nicolai L, Leunig A, Pekayvaz K. Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration [accessed July 29, 2021].Publisher"},{"key":"34937","doi-asserted-by":"crossref","unstructured":"Pfueller SL, Logan D, Tran TT, Bilston RA. Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets. Clin Exp Immunol. 1990; 79(3):367-373.","DOI":"10.1111\/j.1365-2249.1990.tb08097.x"},{"key":"34938","doi-asserted-by":"crossref","unstructured":"Hauler F, Mallery DL, McEwan WA, Bidgood SR, James LC. AAA ATPase p97\/VCP is essential for TRIM21-mediated virus neutralization. Proc Natl Acad Sci U S A. 2012; 109(48):19733-19738.","DOI":"10.1073\/pnas.1210659109"},{"key":"34939","doi-asserted-by":"crossref","unstructured":"Greinacher A, Selleng K, Mayerle J. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021; 138(14):1269-1277.","DOI":"10.1182\/blood.2021012938"},{"key":"34940","doi-asserted-by":"crossref","unstructured":"Uzun G, Althaus K, Bakchoul T. No correlation between anti-PF4 and anti-SARS-CoV-2 antibodies after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021; 385(14):1334-1336.","DOI":"10.1056\/NEJMc2111305"},{"key":"34941","doi-asserted-by":"crossref","unstructured":"Bastian M, Holsteg M, Hanke-Robinson H, Duchow K, Cussler K. Bovine neonatal pancytopenia: is this alloimmune syndrome caused by vaccine-induced alloreactive antibodies?. Vaccine. 2011; 29(32):5267-5275","DOI":"10.1016\/j.vaccine.2011.05.012"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280154\/74062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280154\/74305","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10508\/74062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:56Z","timestamp":1794045656000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.280154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.280154","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-736157\/v1","asserted-by":"object"}]},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}